Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence. - sprookjes - yvandenbroek - TriplyDB

Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence.

Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence.

http://www.wikidata.org/entity/Q33900327

about

Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway.Selective augmentation of stem cell populations in structural fat grafts for maxillofacial surgery.Cell-assisted lipotransfer.Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion.Do Mesenchymal Stromal Cells Influence Microscopic Residual or Metastatic Osteosarcoma in a Murine Model?Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.Scaffold-free Three-dimensional Graft From Autologous Adipose-derived Stem Cells for Large Bone Defect Reconstruction: Clinical Proof of Concept Adipose-derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling.Human adipose stem cell differentiation is highly affected by cancer cells both in vitro and in vivo: implication for autologous fat grafting.Concise review: mesenchymal tumors: when stem cells go mad.Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis.TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models.Drugs in early clinical development for the treatment of osteosarcoma.Development of a cyclosporin-A-induced immune tolerant rat model to test marrow allograft cell type effects on bone repair.New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance.Increased risk of recurrence associated with certain risk factors in breast cancer patients after DIEP-flap reconstruction and lipofilling-a matched cohort study with 200 patients.The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets.Upper extremity sarcoma: impact of current practice guidelines and controversies on reconstructive approaches.Latissimus dorsi flap invasion by ductal breast carcinoma after lipofilling.Evaluation of fat grafting safety in patients with intraepithelial neoplasia: a matched-cohort study.Low-Dose Pesticide Mixture Induces Senescence in Normal Mesenchymal Stem Cells (MSC) and Promotes Tumorigenic Phenotype in Premalignant MSC.Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development.Effect of Adipose-Derived Stem Cells on Head and Neck Squamous Cell Carcinoma.Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications.Biology of Bone Sarcomas and New Therapeutic Developments.Human Adipose-Derived Mesenchymal Stem Cell-Secreted CXCL1 and CXCL8 Facilitate Breast Tumor Growth By Promoting Angiogenesis.Application of a three-dimensional graft of autologous osteodifferentiated adipose stem cells in patients undergoing minimally invasive transforaminal lumbar interbody fusion: clinical proof of concept.Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma.Oncological safety of autologous fat grafting after breast conservative treatment: a prospective evaluation.Effect of ASCs on the graft survival rates of fat particles in rabbits.Locoregional recurrence risk after lipofilling in breast cancer patients

P2860

Q28085040-99A25001-DBB0-4DC2-B97B-44D462064D0D Q33618863-7F9D6203-F515-40BB-94DB-0D54B91AA0D7 Q34465559-18D7FAAC-D957-4D1B-933A-E4AB96916DB1 Q35568502-44C39FC9-C372-4F55-B9B9-958AC71A75A1 Q36194212-12C6AE96-0BD0-4ED3-A2B2-BCDEEC21A762 Q36558616-F9DBF63D-06E8-46DE-85A7-F566CB1A3690 Q36661456-61FCE7DD-011A-4933-83F9-965D2AEB4A75 Q37043780-11228447-BAAF-4906-B3B0-79F31F2A0FDD Q37328298-D8F565FD-E5E3-44D1-9CE2-DBF70E790C55 Q37718453-52A5D4C8-FB60-472A-87FC-76624F3FE293 Q37744842-CBB475A2-6620-4082-A3A1-C92ECF458297 Q37855742-BD9EDDB3-EEA7-46F6-AEDC-1DCCAFE36EA2 Q37962606-81ED4A18-281C-439A-89D0-5C228DCA608A Q38750240-7D85DFD5-B4E8-46DB-BEBF-14E29D747412 Q38955517-57B6DF0C-E695-436C-A37E-C6F0F56E6ABA Q39037470-0B129043-EE2C-4250-BC5A-B75B2D00E8AB Q39108175-F49AF1AE-D293-4C3F-A02A-C6707024385F Q41485550-FF2B22D3-4CC1-4A6D-A303-064AEE3DB283 Q42084526-D6E662C4-95BD-4F0A-93BA-554001F77BBC Q42320535-ED488901-E6C4-4DCD-B898-93888F4C0391 Q42930678-46780141-D1C4-4C88-8321-60A097C79BDB Q45337938-6ACC2465-480F-44D6-8BAD-1F92819DED1F Q46458165-B8AB6485-BD44-4A08-BFC0-8A0FFADF9206 Q47104412-547F102B-D185-4492-9B30-A464704FAEBC Q47191411-47EE4A18-963E-428B-8F40-0F271C5FDBEE Q47701410-3205F963-183A-47A6-A78A-99BC46C7A567 Q48120956-80BFB674-E5E5-4943-91DC-762AB69DBBE6 Q48131192-21DD39EE-475D-43AD-A181-134DB95A08F1 Q50980351-9AD7724E-BDD0-462D-A442-60BA8C5F75AB Q52370993-8BF302EF-D544-465F-BFAE-D3ED4E905DC6 Q53071358-C022D697-3B46-409B-88CF-A2C914CFEB7D Q53131045-5CAE711B-3F77-4311-B662-04E0475BBC80 Q57580723-8E843B3A-4EE6-45DA-8E81-DA4FC1BADD51

P2860

Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence.

http://www.wikidata.org/entity/Q33900327

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Safety concern between autolog ...... l and osteosarcoma recurrence.

@ast

Safety concern between autolog ...... l and osteosarcoma recurrence.

@en

type

label

Safety concern between autolog ...... l and osteosarcoma recurrence.

@ast

Safety concern between autolog ...... l and osteosarcoma recurrence.

@en

prefLabel

Safety concern between autolog ...... l and osteosarcoma recurrence.

@ast

Safety concern between autolog ...... l and osteosarcoma recurrence.

@en

P1433

Q33900327-B288D2D9-D612-4428-A4B3-F4013044DC49

P1476

Q33900327-14F0E00B-E082-4EBA-870D-93B45EE69936

P2093

Q33900327-33C1FB79-B3E7-4D13-8646-73AE5F0876DD

Q33900327-46A1E0DC-F67D-4E22-BB11-32CB9F017058

Q33900327-7EB93DB6-0E00-43AB-8C69-A884B6B3D01A

Q33900327-83098549-8E30-4C9D-A497-22CEE4D33655

Q33900327-8FD16C05-2F73-4FA5-B5A7-1380BE07E7D0

Q33900327-95BD5C4F-74B6-4486-9AF0-7937063515B3

Q33900327-9968BF43-CCFC-451C-B394-14478935699B

Q33900327-C0570EED-9326-483C-8726-3A816A2D0DC3

Q33900327-CCFA9E32-D4F3-4465-9D2A-B006AC6DE793

Q33900327-E5A9CD65-27C0-4695-A100-C1A39173E18A

P2860

Q33900327-01827AD1-5C6F-4319-BD79-FAB2BBB0A20A

Q33900327-04E7C867-FA8A-44E0-9952-793D40DA73B3

Q33900327-0B20BB56-8C9F-4338-B963-2E25F9B93EB8

Q33900327-0B7BEEC6-A8CB-4FEC-964B-A654981D0196

Q33900327-13453726-7BAA-4DB1-9EFA-391F4F5D5947

Q33900327-1E5204B5-1806-43F1-9F75-9C1957568F7F

Q33900327-1F661B63-9C30-4C24-A325-2D68081E8815

Q33900327-20A11AB9-E4F0-4FD1-8BFA-BE0D114BCAB3

Q33900327-283DA1B9-8C05-4AFC-9C51-5F3A62E61012

Q33900327-28ED9813-9E2E-4433-B726-40868DEDCD05

P304

Q33900327-967DC0CB-D5D4-40B2-8BBD-EC06A631180D

P31

Q33900327-3C94B990-6BFF-44E3-99D2-9D5DA5BF31D8

P356

Q33900327-77775A60-027A-4A5C-94D1-10FC3B22AC2E

P407

Q33900327-0599188B-E94F-47F9-A0D2-4307E4277820

P433

Q33900327-CEEB7DCB-A013-461F-B860-003EE81467DD

P478

Q33900327-7245409B-0D6E-483D-AAE6-C668CB69BCB7

P50

Q33900327-4B6C6921-EA7F-4227-8B67-0E74613DEE68

P577

Q33900327-78AEF419-97BA-4B35-877A-B2F12765E12F

P5875

Q33900327-6A5E7E84-A036-41A3-8DDA-02EB7C8B7275

P698

Q33900327-DEDA240B-88B4-4C1A-A143-353093A9A9AB

P932

Q33900327-6FFAC781-AC46-4814-BB64-8B0886E05A74

P356

JOURNAL.PONE.0010999

P1433

P1476

Safety concern between autolog ...... l and osteosarcoma recurrence.

@en

P2093

Anne-Laure Bouffaut

http://www.w3.org/2001/XMLSchema#string

Elisabeth Cassagnau

http://www.w3.org/2001/XMLSchema#string

Franck Duteille

http://www.w3.org/2001/XMLSchema#string

François Gouin

http://www.w3.org/2001/XMLSchema#string

Françoise Rédini

http://www.w3.org/2001/XMLSchema#string

Frédéric Deschaseaux

http://www.w3.org/2001/XMLSchema#string

Julie Rousseau

http://www.w3.org/2001/XMLSchema#string

Marie-Françoise Heymann

http://www.w3.org/2001/XMLSchema#string

Pierre Perrot

http://www.w3.org/2001/XMLSchema#string

Valérie Trichet

http://www.w3.org/2001/XMLSchema#string

P2860

One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice

Molecular biology of bone metastasis.

10T1/2 cells: an in vitro model for molecular genetic analysis of mesodermal determination and differentiation

Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells.

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.

Fat grafting to the breast revisited: safety and efficacy.

Origin and differentiation of human and murine stroma.

Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells.

Stem-like cells in bone sarcomas: implications for tumorigenesis.

Bone and fat: old questions, new insights.

P304

e10999

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0010999

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Heymann

P577

2010-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44669304

http://www.w3.org/2001/XMLSchema#string

P698

20544017

http://www.w3.org/2001/XMLSchema#string

P932

2882323

http://www.w3.org/2001/XMLSchema#string